Physician profile
Ramesh Subedi
NPI 1912155532
$5,045.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $179 · 2021: $829 · 2022: $3,450 · 2023: $152 · 2024: $17.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,909.52 | 2021-2022 | |
| Glaxosmithkline, LLC. | $161.04 | 2019-2023 | Trelegy Ellipta, Nucala |
| Genentech USA, INC. | $153.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $118.16 | 2019-2023 | Airsupra |
| Shionogi INC | $104.10 | 2022-2023 | Fetroja |
| Sunovion Pharmaceuticals INC. | $84.35 | 2019 | |
| Medivance, INC. | $67.42 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $48.15 | 2019-2022 | |
| Inogen, INC. | $39.56 | 2022 | |
| Mallinckrodt Enterprises LLC | $36.83 | 2019 | |
| Potrero Medical, INC. | $33.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $32.46 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.35 | 2023 | Glassia |
| United Therapeutics Corporation | $20.10 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.54 | 2024 | |
| Harmony Biosciences LLC | $17.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.13 | 2022 | |
| Merck Sharp & Dohme LLC | $14.41 | 2019 | |
| Circassia INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Subedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.